Optimizing Electrostatic Similarity for Virtual Screening: A New Methodology

[1]  A. Moon,et al.  A natural piper-amide-like compound NED-135 exhibits a potent inhibitory effect on the invasive breast cancer cells. , 2015, Chemico-biological interactions.

[2]  J. A. Grant,et al.  Potent fibrinolysis inhibitor discovered by shape and electrostatic complementarity to the drug tranexamic acid. , 2013, Journal of medicinal chemistry.

[3]  Y. Pommier,et al.  Discovery of selective inhibitors of tyrosyl-DNA phosphodiesterase 2 by targeting the enzyme DNA-binding cleft. , 2016, Bioorganic & medicinal chemistry letters.

[4]  Juana López Redondo,et al.  Preference-based multi-objectivization applied to decision support for High-Pressure Thermal processes in food treatment , 2019, Appl. Soft Comput..

[5]  Yuegang Zhang,et al.  The potency-insolubility conundrum in pharmaceuticals: Mechanism and solution for hepatitis C protease inhibitors. , 2015, Biophysical chemistry.

[6]  Kunal Roy,et al.  How far can virtual screening take us in drug discovery? , 2013, Expert opinion on drug discovery.

[7]  Anthony Nicholls,et al.  Analysis of SM8 and Zap TK calculations and their geometric sensitivity , 2010, J. Comput. Aided Mol. Des..

[8]  Alberto Massarotti,et al.  ZINClick: A Database of 16 Million Novel, Patentable, and Readily Synthesizable 1, 4-Disubstituted Triazoles , 2014, J. Chem. Inf. Model..

[9]  Boglárka G.-Tóth,et al.  A planar single-facility competitive location and design problem under the multi-deterministic choice rule , 2017, Comput. Oper. Res..

[10]  Dusanka Janezic,et al.  LiSiCA: A Software for Ligand-Based Virtual Screening and Its Application for the Discovery of Butyrylcholinesterase Inhibitors , 2015, J. Chem. Inf. Model..

[11]  J. A. Grant,et al.  A fast method of molecular shape comparison: A simple application of a Gaussian description of molecular shape , 1996, J. Comput. Chem..

[12]  Juan G. Santiago,et al.  Modelling and optimization applied to the design of fast hydrodynamic focusing microfluidic mixer for protein folding , 2018, Journal of Mathematics in Industry.

[13]  Pengyu Ren,et al.  From in Silico Discovery to intra-Cellular Activity: Targeting JNK-Protein Interactions with Small Molecules. , 2012, ACS medicinal chemistry letters.

[14]  Francesca Perruccio,et al.  HPPD: Ligand- and Target-Based Virtual Screening on a Herbicide Target , 2010, J. Chem. Inf. Model..

[15]  Pekka Tiikkainen,et al.  Critical Comparison of Virtual Screening Methods against the MUV Data Set , 2009, J. Chem. Inf. Model..

[16]  Hongwei Jin,et al.  Discovery of new GSK-3β inhibitors through structure-based virtual screening. , 2018, Bioorganic & medicinal chemistry letters.

[17]  Pin-Chih Su,et al.  Discovery of a novel and potent class of F. tularensis enoyl-reductase (FabI) inhibitors by molecular shape and electrostatic matching. , 2012, Journal of medicinal chemistry.

[18]  Guo-Wei Wei,et al.  Parameterization of a geometric flow implicit solvation model , 2013, J. Comput. Chem..

[19]  Jae U. Jung,et al.  Peptide inhibition of p22phox and Rubicon interaction as a therapeutic strategy for septic shock. , 2016, Biomaterials.

[20]  Ashutosh Kumar,et al.  Application of Shape Similarity in Pose Selection and Virtual Screening in CSARdock2014 Exercise , 2016, J. Chem. Inf. Model..

[21]  P. M. Ortigosa,et al.  OptiPharm: An evolutionary algorithm to compare shape similarity , 2019, Scientific Reports.

[22]  M. Botta,et al.  A fast virtual screening approach to identify structurally diverse inhibitors of trypanothione reductase. , 2011, Bioorganic & medicinal chemistry letters.

[23]  Xiaofeng Liu,et al.  SHAFTS: A Hybrid Approach for 3D Molecular Similarity Calculation. 1. Method and Assessment of Virtual Screening , 2011, J. Chem. Inf. Model..

[24]  Oakland J. Peters,et al.  Predicting new indications for approved drugs using a proteochemometric method. , 2012, Journal of medicinal chemistry.

[25]  Ana Rodriguez,et al.  Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation. , 2017, European journal of medicinal chemistry.

[26]  Wei Li,et al.  Identifying Novel Molecular Structures for Advanced Melanoma by Ligand-Based Virtual Screening , 2009, J. Chem. Inf. Model..

[27]  M. Gochin,et al.  Identification of fragments targeting an alternative pocket on HIV-1 gp41 by NMR screening and similarity searching. , 2013, Bioorganic & medicinal chemistry letters.

[28]  Julen Oyarzabal,et al.  Novel approach for chemotype hopping based on annotated databases of chemically feasible fragments and a prospective case study: new melanin concentrating hormone antagonists. , 2009, Journal of medicinal chemistry.

[29]  Chang-Guo Zhan,et al.  Ligand-Based Virtual Screening Approach Using a New Scoring Function , 2012, J. Chem. Inf. Model..

[30]  J. A. Grant,et al.  A Gaussian Description of Molecular Shape , 1995 .

[31]  Gábor Imre,et al.  Screen3D: A Novel Fully Flexible High-Throughput Shape-Similarity Search Method , 2014, J. Chem. Inf. Model..

[32]  Ashutosh Kumar,et al.  Advances in the Development of Shape Similarity Methods and Their Application in Drug Discovery , 2018, Front. Chem..

[33]  Gary Tresadern,et al.  A comparison of ligand based virtual screening methods and application to corticotropin releasing factor 1 receptor. , 2009, Journal of molecular graphics & modelling.

[34]  Paul C D Hawkins,et al.  Ligand-Based Methods in GPCR Computer-Aided Drug Design. , 2018, Methods in molecular biology.

[35]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[36]  T. Halgren.  Potential energy functions. , 1995, Current opinion in structural biology.

[37]  Minghao Zheng,et al.  Enhancing Molecular Shape Comparison by Weighted Gaussian Functions , 2013, J. Chem. Inf. Model..

[38]  Zheng Zhu,et al.  Structure‐based discovery of clinically approved drugs as Zika virus NS2B‐NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo , 2017, Antiviral research.